Acidic (Leucine-Rich) Nuclear phosphoprotein 32 Family, Member B (ANP32B) (N-Term) Peptide
ANP32B
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN973242
Quick Overview for Acidic (Leucine-Rich) Nuclear phosphoprotein 32 Family, Member B (ANP32B) (N-Term) Peptide (ABIN973242)
Target
ANP32B
(Acidic (Leucine-Rich) Nuclear phosphoprotein 32 Family, Member B (ANP32B))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-ANP32B antibody (Catalog #: ARP52175_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ANP32B (Acidic (Leucine-Rich) Nuclear phosphoprotein 32 Family, Member B (ANP32B))
-
Background
-
ANP32B is a multifunctional protein working as a cell cycle progression factor as well as a cell survival factor. ANP32B is required for the progression from the G1 to the S phase. ANP32B is an anti-apoptotic protein which functions as a caspase-3 inhibitor. It has no phosphatase 2A (PP2A) inhibitor activity.
Alias Symbols: APRIL, PHAPI2, SSP29
Protein Interaction Partner: ELAVL1,POLR1A,MEPCE
Protein Size: 251 -
Molecular Weight
- 29 kDa
-
Gene ID
- 10541
-
NCBI Accession
- NM_006401, NP_006392
-
UniProt
- Q92688
Target
-
You are here:
